T cells to the rescue?

Affiliations

Comment

Jeremy Pantin et al. Br J Haematol. 2022 Feb.

. 2022 Feb;196(3):466-467.

doi: 10.1111/bjh.17915. Epub 2021 Oct 25.

¹ Tristar Centennial Blood and Marrow Transplant, Sarah Cannon Blood Cancer Network, Nashville, TN, USA.

No abstract available

Comment on

T-cell immune response after mRNA SARS-CoV-2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies.
Marasco V, Carniti C, Guidetti A, Farina L, Magni M, Miceli R, Calabretta L, Verderio P, Ljevar S, Serpenti F, Morelli D, Apolone G, Ippolito G, Agrati C, Corradini P. Marasco V, et al. Br J Haematol. 2022 Feb;196(3):548-558. doi: 10.1111/bjh.17877. Epub 2021 Oct 14. Br J Haematol. 2022. PMID: 34649298 Free PMC article. Clinical Trial.

1. Andrick B, Alwhaibi A, DeRemer DL, Quershi S, Khan R, Bryan LJ, et al. Lack of adequate pneumococcal vaccination response in chronic lymphocytic leukaemia patients receiving ibrutinib. Br J Haematol. 2018;182:712-4.
1. Ehmsen S, Asmussen A, Jeppesen SS, Nilsson AC, Østerlev S, Vestergaard H, et al. Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer. Cancer Cell. 2021;39(8):1034-6.
1. Addeo A, Shah PK, Bordry N, Hudson RD, Albracht B, Di Marco M, et al. Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer. Cancer Cell. 2021;39:1091-8.e2.
1. Thakkar A, Gonzalez-Lugo JD, Goradia N, Gali R, Shapiro LC, Pradhan K, et al. Seroconversion rates following COVID-19 vaccination among patients with cancer. Cancer Cell. 2021;39:1081-90.e2.
1. Chavarot N, Ouedrani A, Marion O, Leruez-Ville M, Vilain E, Baaziz M, et al. Poor anti-SARS-CoV-2 humoral and T-cell responses after 2 injections of mRNA vaccine in kidney transplant recipients treated with belatacept. Transplantation. 2021;105:e94-5.